SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases

SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases is a phase 2, interventional study registered as NCT05775146 by AHS Cancer Control Alberta, with a registry enrolment figure of 24 participants, started 2024-06-18 and due to reach its primary completion in 2028-06-30. Interventions recorded: stereotactic body radiation treatment (SBRT). Conditions listed: Colorectal Cancer; Liver Metastasis Colon Cancer. Primary outcome: Progression free survival (PFS). Colorectal eligibility wording from the registry: "* Colon cancer patients who have undergone upfront resection of primary colonic lesion can be included". Sites: Canada. No results are recorded here; the registry entry is the source.